Nabriva Therapeutics plc Earnings Per Share, Basic and Diluted
Nabriva Therapeutics plc reported Earnings Per Share, Basic and Diluted of -$0.53 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-06
- Nabriva Therapeutics plc earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.53.
- Nabriva Therapeutics plc earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.09.
- Nabriva Therapeutics plc earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.14.
- Nabriva Therapeutics plc earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$2.46.
- Nabriva Therapeutics plc earnings per share, basic and diluted for fiscal 2020 was -$5.41.
- Nabriva Therapeutics plc earnings per share, basic and diluted for fiscal 2019 was -$11.15.
- Nabriva Therapeutics plc earnings per share, basic and diluted for fiscal 2018 was -$22.60.
- Nabriva Therapeutics plc earnings per share, basic and diluted for fiscal 2017 was -$2.49.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-03-31 | -$0.53 10-Q · filed 2021-05-06 | |||||
| 2020-12-31 | -$5.41 10-K · filed 2021-03-11 | |||||
| 2020-09-30 | -$0.09 10-Q · filed 2020-11-05 | -$0.44 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | -$0.14 10-Q · filed 2020-08-06 | -$0.37 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | -$2.46 10-Q · filed 2021-05-06 | -$0.25 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | -$0.29 10-K · filed 2020-03-12 | -$11.15 10-K · filed 2021-03-11 | -$1.12 10-K · filed 2020-03-12 | |||
| 2019-09-30 | -$0.24 10-Q · filed 2020-11-05 | -$0.83 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | -$0.30 10-Q · filed 2020-08-06 | -$0.59 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | -$0.29 10-Q · filed 2020-05-11 | |||||
| 2018-12-31 | -$0.46 10-K · filed 2020-03-12 | -$22.60 10-K · filed 2021-03-11 | -$2.26 10-K · filed 2019-03-12 | |||
| 2018-09-30 | -$0.90 10-K · filed 2020-03-12 | -$1.85 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$0.44 10-K · filed 2020-03-12 | -$0.80 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | -$0.36 10-K · filed 2020-03-12 | |||||
| 2017-12-31 | -$0.61 10-K · filed 2019-03-12 | -$2.49 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$0.79 10-K · filed 2019-03-12 | -$1.89 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | -$0.54 10-K · filed 2019-03-12 | -$1.10 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | -$0.56 10-Q · filed 2018-05-08 | |||||
| 2016-12-31 | -$2.56 10-K · filed 2019-03-12 | |||||
| 2016-09-30 | -$0.66 10-Q · filed 2017-11-09 | -$1.87 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | -$0.57 10-Q · filed 2017-08-07 | -$1.21 10-Q · filed 2017-08-07 | ||||
| 2015-12-31 | -$4.80 10-K · filed 2018-03-16 |